EPS

A medical breakthrough dismantles a core barrier in cancer treatment, making stem cell transplants a reality for nearly everyone, regardless of ancestry.

The global caterer's share repurchase signals more than financial health; it's a strategic move to fuel growth, reward investors, and reshape its future.

A PE firm's operational overhaul of a corporate carve-out leads to a strategic sale, highlighting the consolidation and tech trends reshaping security.

Danone's latest share buyback isn't just a financial maneuver. It’s a strategic move to boost employee ownership while protecting shareholder value.

The firm’s steady dividend is not just a routine payout. It's a signal of financial strength, a strategic balance of growth, and a key tax advantage.